|
Phone: +1 714 2464500 |
Address:
2525 DUPONT DRIVE
IRVINE, CA 92612 |
Company Description
Allergan Specialty Therapeutics, Inc. a development stage company, conducts research and development of potential human pharmaceutical products and commercializes such products through licensing. The company's research and development is focused on various pharmaceutical products such as tazarotene for the treatment of cancer, acne and psoriasis, memantine, a treatment to be used to halt the progression of optic nerve damage and AGN 194310 for the topical treatment of psoriasis. Tazaroptene is currently marketed under the brand name "Tazorac(R)" in the United States and "Zorac(R)" outside the United States.
Key People
| Chairman, President & Chief Exec | W.C. SHEPHERD |
| Chief Financial Officer | J.M. HINDMAN |
| Secretary | D.S. INGRAM |
Related Business Topics
Breaking News
Reuters - Nov. 20, 2009, 5:27 AM
Forbes.com - Oct. 29, 2009, 12:57 PM
Forbes.com - Oct. 27, 2009, 3:50 AM
Forbes.com - Oct. 22, 2009, 3:56 AM
Forbes.com - Oct. 21, 2009, 4:43 PM
More Allergan Specialty Therapeut News
Official Site - Allergan
RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%. Learn More.
RESTASIS.com
RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%. Learn More.
RESTASIS.com

